PA Medical News about Diabetic Neuropathies Pain

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Prevalence and impact of pain in diabetic neuropathy
European Diabetes Nursing, 10/21/09

Geerts M et al. – The prevalence of severe painful DNP (PDNP) was high (57.5%). Severity of diabetic neuropathy (DNP) was not related to pain severity. PDNP was associated with loss of QoL and with symptoms of anxiety and depression. A considerable proportion of patients did not have medical treatment and, if treatment was given, its impact was disappointing. Medical treatment of PDNP was unsatisfactory and clearly needs to be improved.

Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State
Journal of Opioid Management, 11/03/09 Relevance Score: 82%

New diagnostic tests for diabetic distal symmetric polyneuropathy
Journal of Diabetes and its Complications, 11/13/09 Relevance Score: 81%

A Randomized Clinical Trial of the Effectiveness of Photon Stimulation on Pain, Sensation, and Quality of Life in Patients With Diabetic Peripheral Neuropathy
Journal of Pain and Symptom Management, 11/09/09 Relevance Score: 81%

Duloxetine for treating painful neuropathy or chronic pain
Cochrane Reviews, 10/08/09 Relevance Score: 81%

Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial
Diabetic Medicine, 10/01/09 Relevance Score: 80%